Skip to content

Influence of Coffee on the Health and on the Heart of Normal, Diabetics e Coronary Artery Disease Patients

Study of Coffee and Its Influence on the Heart in Normal People, Those With Coronary Artery Disease and Diabetics.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01003392
Acronym
Coffee&Heart
Enrollment
300
Registered
2009-10-28
Start date
2008-03-31
Completion date
2014-12-31
Last updated
2014-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Coronary artery disease, Coffee, Heart system

Brief summary

Coffee is a worldwide drink, been part of any culture. There are some concerns about effects of coffee on the health. Recently, epidemiological studies have shown benefits of coffee drinking to diabetics and also to prevent diabetes in populations. We aim to understand some effects of coffee and not only caffeine over vascular system, in special coronary artery disease patients, diabetics end normal people.

Detailed description

Patients will have a wash-out period (21 days) with no coffee or other caffeine-drinks. Then they will be submitted to treadmill test, MAPA, Holter-ECG and vascular reactivity study, biochemical and inflammatory plasma dosages, as basal. Then they will start a period of coffee drinking over 4 weeks; and all exams will be repeated. We will study two types of coffee, arabica and robusta; with two types of toasted beans(regular and soft). Also regular and decaffeinated coffee. A total of 300 (100 normal people, 100 diabetics, 100 coronary disease) individuals will be tested.

Interventions

None listed

Sponsors

Feculdade de Medicina da Universidade de Sao Paulo - Brasil
CollaboratorOTHER
University of Sao Paulo
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Normal Volunteers: 1. Healthy volunteer. 2. Age between 20 and 80 years. 3. No addict to drugs. 4. Absence of chronicle diseases. 5. No alcohol abuse. 6. No smoker. Coronary artery disease: 1. Presence of coronary artery disease, by coronary angiography 2. Stable angina, class 1-3 of CCS. 3. Age between 20 and 80 years. 4. Treadmill effort test with ischemia. 5. No alcohol abuse. 6. No smoker. Diabetes: 1. Presence of type II Diabetes on oral treatment. 2. Age between 20 and 80 years. 3. Absence of chronicle diseases, except diabetes. 4. No alcohol abuse. 5. No smoker.

Exclusion criteria

Normal Volunteers: 1. Any blood test with twice or more the upper limit range. 2. Presence of enlarged QRS. Coronary artery disease: 1. Any blood test with twice or more the upper limit range even with treatment. 2. Presence of enlarged QRS. 3. Ventricular dysfunction (EF \< 45%). Diabetes: 1. Blood glucose greater than 160 mg/dL. 2. Others blood tests with twice or more the upper limit range even with treatment. 3. Presence of enlarged QRS.

Design outcomes

Primary

MeasureTime frame
Verify the relationship between coffee ingestion and cardiovascular morbidity and mortality10 years of follow-up

Secondary

MeasureTime frame
Relationship between coffee ingestion and cardiovascular risk factors10 years

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026